International Journal of Coronaviruses

Aims and Scope

International Journal of Coronaviruses (ISSN: 2692-1537) is a dedicated platform for the latest and most impactful research in the field of coronavirus studies, particularly focusing on the global implications of the COVID-19 pandemic. As an open-access journal, it ensures that critical findings are accessible to researchers, healthcare professionals, and policymakers worldwide. Our goal is to advance the understanding and treatment of coronaviruses through peer-reviewed publications, promoting interdisciplinary collaboration and innovation in this crucial area of infectious disease research.

1. Coronavirus Virology:

Our journal emphasizes the molecular biology, genetics, and replication mechanisms of coronaviruses, including SARS-CoV-2 research. This section covers the detailed study of viral structures, life cycles, and mutations that contribute to the ongoing evolution of these pathogens.

2. Epidemiology and Public Health:

We publish cutting-edge research on the epidemiology of coronaviruses, including the spread, control, and prevention of outbreaks. This section highlights the global impact of coronaviruses on public health systems, offering insights into effective mitigation strategies.

3. Clinical Manifestations and Treatment:

The journal covers the clinical aspects of coronavirus infections, including symptoms, diagnostics, and therapeutic approaches. Research on coronavirus treatment development and COVID-19 clinical studies is prominently featured, providing valuable information for healthcare providers and researchers alike.

4. Vaccines and Immunology:

A critical focus of the journal is the research on vaccine development, immune responses, and coronavirus vaccine efficacy studies. This includes the study of different vaccine candidates, their clinical trials, and the long-term effectiveness in preventing infections.

5. Coronavirus Variants:

We explore the genetic diversity and emerging variants of coronaviruses, particularly SARS-CoV-2 transmission and mutation studies. Notable variants such as Alpha, Beta, Delta, and Omicron are examined for their impact on transmissibility, vaccine efficacy, and public health measures. Understanding these variants is key to adapting public health measures and treatment protocols to the evolving nature of the pandemic.

6. Interdisciplinary Research:

The journal recognizes that COVID-19 and coronaviruses are interdisciplinary subjects that intersect with virology, immunology, epidemiology, pharmacology, and public health. We encourage submissions that bridge these fields, offering comprehensive insights into the multifaceted challenges posed by coronaviruses.

7. Technological and Methodological Advances:

This section is dedicated to advancements in diagnostic tools, therapeutic innovations, and research methodologies that are shaping the future of coronavirus diagnostics and testing research. We seek contributions that push the boundaries of current technologies and propose new approaches to studying and combating coronaviruses.

The International Journal of Coronaviruses periodically publishes special issues focusing on key topics such as COVID-19 studies, vaccine development, and emerging variants. These thematic issues gather the latest research from around the globe, highlighting global coronavirus research contributions and fostering a deeper understanding of the pandemic's ongoing challenges.

A few keywords are listed below which suit the scope of the journal but are not strictly confined to them. For questions or queries, you can reach us.

• COVID-19 Genome Surveillance
• Cross-reactive T-cell Immunity
• AI in COVID-19 Diagnosis
• Nanotechnology in COVID-19 Vaccines
• COVID-19 Airborne Transmission
• COVID-19 Reinfection Rates
• Paediatric COVID-19 Cases
• COVID-19 Immunization Strategies
• mRNA Vaccine Development
• COVID-19 Vaccine Distribution Logistics
• Global Vaccine Equity
• COVID-19 Digital Health Tools
• COVID-19 Bioinformatics
• COVID-19 Cytokine Storm
• Viral Load and Disease Severity
• COVID-19 Reinfection Mechanisms
• COVID-19 and Autoimmune Disorders
• COVID-19 Immune Evasion
• Impact of COVID-19 on Mental Health
• COVID-19 Predictive Modelling
• Infection Control and COVID-19
• COVID-19 Therapeutic Development
• COVID-19 Vaccination in Special Populations
• Comparative COVID-19 Immunogenicity
• COVID-19 Vaccine Adjuvants
• Pandemic Response Coordination
• SARS-CoV-2 Antibody Profiling
• COVID-19 Antiviral Resistance
• Telemedicine in Pandemic Response
• COVID-19 Environmental Persistence
• COVID-19 Economic Recovery
• COVID-19 Herd Immunity Thresholds
• Adaptive Immunity in COVID-19
• COVID-19 Diagnostic Innovations
• COVID-19 Virus Shedding Dynamics
• COVID-19 Contact Tracing Technologies
• COVID-19 Non-Pharmaceutical Interventions
• COVID-19 Health Policy Responses
• COVID-19 Clinical Trials Design
• COVID-19 Vaccine Boosters
• COVID-19 Multisystem Inflammatory Syndrome in Children (MISC)
• COVID-19 Neurological Manifestations
• COVID-19 Genomic Epidemiology
• Longitudinal COVID-19 Studies
• COVID-19 Vaccine-Induced Immunity
• COVID-19 Impact on Chronic Diseases
• COVID-19 Public Health Infrastructure
• COVID-19Related Healthcare Costs
• COVID-19 Vaccine Hesitancy Driver
• Global Impact and Socioeconomic Factors
• COVID-19 Prevention and Control
• Ethical and Legal Issues in COVID-19
• Vaccine mandates and Ethical Considerations
• Privacy issues in Contact Tracing
• Legal aspects of Pandemic Response
• Human Rights During COVID-19 Pandemic